Any reference to biological activity or potential effects is based solely on preclinical or invitro findings and should not be interpreted as validated clinical outcomes
748 Inhibition of this pathway using the PAR1 antagonist vorapaxar has been shown to reduce the burden of senescent cells, offering a potential therapeutic strategy
BPC-157/TB-500/KPV/GHK-Cu 10+10+10+50mg (KLOW blend 80mg) $225.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC+TB500+GHK-Cu+KPV SYNONYMS KLOW blend CAS NUMBER 137525-51-0 (BPC-157), 77591-33-4 (TB500), 300801-03-0 (GHK-Cu), 2828433-34-5 (KPV) MOLECULAR FORMULA C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) MOLECULAR WEIGHT ~7189 g/mol STRUCTURE Multi-peptide blend PEPTIDE SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (BPC-157), Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (TB500), Gly-His-Lys (GHK-Cu), Lys-Pro-Val (KPV) CHEMICAL STRUCTURE Molecular Formula : C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu), C 18 H 34 N 4 O 6 (KPV) Source: PubChem Mechanism of Action The KLOW blend acts on multiple cellular pathways that regulate inflammation, tissue repair, angiogenesis, and oxidative balance
B.YangG.LiH.GaoJ.et al (2011)
Pharmacological treatments may be considered in specific circumstances under specialist supervision
This time period includes the transit time for us to receive your return from the shipper (5 to 10 business days), the time it takes us to process your return once we receive it (3 to 5 business days), and the time it takes your bank to process our refund request (5 to 10 business days)
